# HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

Source: https://onco.cc/trials/nct06217042/  
OnCo record `nct06217042` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), leucovorin (folinic acid), gemcitabine and other drugs in pancreatic cancer, run by Fudan University, not yet recruiting.

## Summary

HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer is a phase 3, randomised interventional study registered as NCT06217042 by Fudan University, with a registry enrolment figure of 524 participants, started 2024-02-05 and due to reach its primary completion in 2027-03-30. Interventions recorded: HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate; gemcitabine; capecitabine. Conditions listed: Pancreatic Cancer. Primary outcome: Disease-free survival (DFS). Pancreatic eligibility wording from the registry: "Histologically confirmed resected ductal pancreatic adenocarcinoma with macroscopic complete resection (R0 and R1)". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06217042
- Phase: 3
- Setting: HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate Versus Gemcitabine in Combination With Capecitabine as Adjuvant Therapy for Pancreatic Cancer: an Open, Randomized, Multicenter Phase III Trial.
- Sponsor: Fudan University
- Enrolled: 524

## Sources

- ClinicalTrials.gov NCT06217042: https://clinicaltrials.gov/study/NCT06217042

## Connected records

- cancers: [Resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/resectable-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Topoisomerase-I inhibitors (and ADC payloads)](https://onco.cc/technologies/topoisomerase-inhibitors/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/), [CAPOX (capecitabine, oxaliplatin)](https://onco.cc/drugs/capox/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Leucovorin (folinic acid)](https://onco.cc/drugs/leucovorin/), [Liposomal irinotecan](https://onco.cc/drugs/liposomal-irinotecan/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06217042.json